Search tips
Search criteria 


Logo of bmjThis ArticleThe BMJ
BMJ. 2010; 340: c1471.
Published online 2010 May 13. doi:  10.1136/bmj.c1471
PMCID: PMC2869402

Strength of association between umbilical cord pH and perinatal and long term outcomes: systematic review and meta-analysis

Gemma L Malin, clinical research fellow,1 Rachel K Morris, clinical research fellow,1 and Khalid S Khan, professor of obstetrics, gynaecology, and clinical epidemiology1,2


Objective To evaluate the association between umbilical cord pH at birth and long term outcomes.

Design Systematic review and meta-analysis.

Data sources Medline (1966-August 2008), Embase (1980-August 2008), the Cochrane Library (2008 issue 8), and Medion, without language restrictions; reference lists of selected articles; and contact with authors.

Study selection Studies in which cord pH at birth was compared with any neonatal or long term outcome. Cohort and case-control designs were included.

Results 51 articles totalling 481 753 infants met the selection criteria. Studies varied in design, quality, outcome definition, and results. Meta-analysis carried out within predefined groups showed that low arterial cord pH was significantly associated with neonatal mortality (odds ratio 16.9, 95% confidence interval 9.7 to 29.5, I2=0%), hypoxic ischaemic encephalopathy (13.8, 6.6 to 28.9, I2=0%), intraventricular haemorrhage or periventricular leucomalacia (2.9, 2.1 to 4.1, I2=0%), and cerebral palsy (2.3, 1.3 to 4.2, I2=0%).

Conclusions Low arterial cord pH showed strong, consistent, and temporal associations with clinically important neonatal outcomes that are biologically plausible. These data can be used to inform clinical management and justify the use of arterial cord pH as an important outcome measure alongside neonatal morbidity and mortality in obstetric trials.


Perinatal asphyxia is a major cause of neonatal and childhood morbidity and mortality and has been associated with neonatal death1; hypoxic ischaemic encephalopathy and seizures2 3; intraventricular haemorrhage4; cerebral palsy5; and delayed development.5 Perinatal asphyxia is predicated by fetal acidosis, determined by umbilical cord pH at birth.6 Cerebral palsy is thought to occur more frequently at an arterial cord pH of <7.00 and a base deficit of ≥12 mmol/l.7 These criteria, however, have been derived through consensus, not through evaluation of collated summaries of evidence,7 leading to clinical uncertainty.8 This is because existing observational studies of the association between cord pH and outcomes have drawn inconsistent inferences, partly as a result of the different thresholds used to define abnormality, the variety of outcomes evaluated, and the different variables measured (arterial cord pH, venous cord pH, or base excess).9 10 11 It has been suggested that neonatal complications are associated with metabolic rather than respiratory acidosis.12 13 Respiratory acidosis arises in the early stages of impaired blood supply to the fetus; hypoxaemia and hypercapnia occur, leading to a reduction in pH with a normal base excess.6 If hypoxia is prolonged, anaerobic metabolism results and base excess rises secondary to the presence of lactic acidosis.

On the basis of nine studies, a review14 claimed an association between fetal acidosis and neonatal death and cerebral palsy. This review was, however, carried out in the late 1990s, during which time new studies on the subject have been published and guidelines produced on the methodology and reporting of systematic reviews, including quality assessment of included studies, which were not in widespread use at the time of the review’s publication.15 Substantial uncertainty therefore remains about the value clinicians may attach to acidosis in the clinical management of neonates and the long term implications of a low arterial cord pH. However, cord pH is also commonly used as an outcome measure in obstetric clinical trials16 17 18 and it is one of the bench marks by which obstetricians judge their performance on the labour ward.19 A documented low cord pH is a factor that may be used to support medico-legal claims of harm during intrapartum events resulting in long term disability.20 It is therefore imperative that the validity of this association is supported with high quality evidence. We carried out a comprehensive systematic review of the literature to quantitatively establish the strength of association of acidosis at birth with neonatal mortality, morbidity, and long term outcomes and to assess if causal criteria were met.21


This systematic review was protocol driven using widely recommended methods for reviews22 23 24 and evaluation of causal associations.21 25 26 27 28 The review was carried out and has been reported according to MOOSE guidance.15

We searched Medline (1966-August 2008), Embase (1980-August 2008), the Cochrane Library (2008 issue 8), and Medion for relevant published articles. To identify “grey” literature we also searched SIGLE, Web of Science, the national research register, and medical conferences register. For the Medline search (also see web extra on we used a combination of MeSH headings, such as umbilical cord, hydrogen-ion concentration, or asphyxia neonatorum; keywords, such as umbilical artery pH and cord pH; and word variants using “OR” for capturing citations of the relevant text. To capture relevant outcomes we combined these using “AND” with a combination of MeSH headings, such as human development and infant mortality; keywords, such as developmental delay and handicap; and word variants. We restricted the search to human studies but applied no language restrictions. We adapted the Medline search strategy for use in other databases. We also hand searched recent major journals. Two investigators (RKM and GLM) carried out the search. Using Reference Manager 11.0, we constructed a comprehensive database collating all citations.

Study selection and data extraction

Two reviewers (RKM or GLM, partly in duplicate) scrutinised the database and obtained full articles of all citations potentially meeting the predefined selection criteria. Translations of articles in languages other than English were obtained. Two reviewers (GLM and RKM or ZL) included or excluded studies in accordance with the most recent guidance,23 using strict adherence to the following criteria: population—infants with cord blood obtained at birth; index test—cord blood examined for arterial or venous pH or base excess; outcome—any measure of compromise of neonatal or childhood wellbeing, such as mortality; neonatal morbidity, including hypoxic ischaemic encephalopathy, seizures, intraventricular haemorrhage, periventricular leucomalacia, and long term outcomes, including cerebral palsy; and study design—observational studies that allowed generation of a 2×2 table (true positives, false positives, false negatives, and true negatives) to compute an estimate of the association between test result and outcomes. We excluded studies with five or fewer cases, because of unreliability.

The manuscripts were examined for duplicated populations. If any were found we selected the most recent and complete version. No language restrictions were applied in study selection. We scrutinised the reference lists of selected studies and review articles and obtained additional relevant articles. Two researchers (GLM and RKM or ZL) used a data collection sheet to extract information in duplicate from the selected articles. Data were extracted on study characteristics, quality, and results, and entered onto an Excel spreadsheet. Data were used to construct 2×2 tables of the association between the cord blood variable at the threshold reported in the paper and the postnatal outcome for each infant. When data were thought to be relevant but 2×2 tables could not be constructed, we contacted the relevant authors. Difficulties in data extraction were resolved by discussion with a third reviewer (KSK).

Study quality assessment

We assessed those articles meeting the selection criteria for methodological quality, defined as the confidence that the study design, conduct, and analysis minimised bias in estimation of the association. The articles were assessed using the complete STARD and QUADAS checklists.29 30 These are guidelines for reporting, and methodological quality of, studies on diagnostic accuracy. As the focus of this review was to determine association, the checklist items thought to be most relevant were selected for the purpose of defining the overall quality of included studies and to divide the studies according to quality for meta-analysis and metaregression, in accordance with published guidance.23 We did not assign a quality score as this has been shown to give flawed results.31 We considered the cohort study design to be superior to the case-control design, and we considered the cohort design as a covariate in metaregression. Because of the small number of studies included in each meta-analysis we did not think it appropriate to consider each remaining quality item as an individual covariate for metaregression,32 and we therefore divided the studies into two categories on the basis of several criteria. We rated a study as being of high quality if it had at least four of the following items: adequate description of population, adequate description of the test and outcome measure, consecutive recruitment, prospective recruitment, more than 90% completion of follow-up, appropriate outcome measurement, blinding of the investigators carrying out the outcome measure, and a statement on the use of intervention between the index test and outcome. When a study adhered to three or fewer of these criteria we considered it to be of medium or low quality.

Data synthesis

We used 2×2 tables to compute odds ratios and 95% confidence intervals for each pair of index test and outcome. The odds ratio was selected as the summary statistic as it is relatively constant regardless of the test threshold33 and is often used to show an epidemiological association.34 It represents the effect of the exposure on the odds in an unbiased fashion and enables linkage between the results of case-control and cohort studies.34 As the focus of this review was to establish the association between cord pH and adverse outcome rather than the value of cord pH as a prognostic test, we did not calculate other summary statistics (including sensitivity, specificity, and likelihood ratios). We calculated the estimated predictive interval for each meta-analysis, which relates to the effect of a new study that would be eligible for inclusion in meta-analysis and therefore allows the full uncertainty around inferences to be calculated, including both magnitude and consistency.35

When tables contained cells with a value of 0, we added 0.5 to these cells to allow the calculation of variances.36 Analyses were done for groups defined a priori according to index test (arterial cord pH, venous cord pH, and base excess). The main outcome measures considered were neonatal mortality, a composite measure of neonatal morbidity, and cerebral palsy. To maximise the number of events that could be included in the analysis and to avoid the need to select a single morbidity as a primary outcome measure, we used a composite outcome measure for neonatal morbidity. However, a hazard of composite outcome measures is the assumption that the significance of the result applies to all components.37 To deal with this, we analysed the component outcomes of hypoxic ischaemic encephalopathy, seizures, intraventricular haemorrhage, or periventricular leucomalacia. When the composite outcome measure was used, we took care to ensure that each individual was counted only once in each analysis, particularly when studies reported multiple outcomes for a single population. When multiple outcomes and test thresholds were reported, we attempted to select the most consistent threshold and outcome across the composite analysis—for example, where studies reported on hypoxic ischaemic encephalopathy, seizures, and intraventricular haemorrhage, we included hypoxic ischaemic encephalopathy and seizures in the meta-analysis as we believed this to be more clinically consistent and overall the more common outcome across the included studies.

We plotted odds ratios data in forest plots, assessing heterogeneity visually and statistically using the I2 statistic, a scale that measures the degree of heterogeneity across studies in a meta-analysis.38 Within the largest groups (arterial cord pH paired with neonatal mortality and neonatal morbidity) we explored the reasons for heterogeneity using metaregression, planned a priori in keeping with published recommendations.39 40 We considered study design (cohort v case-control), study quality (high v medium or low), and population risk (high v low/unselected or unreported) as potential sources of heterogeneity. We defined a population at high risk for complications on the basis of reported characteristics, including abnormalities on cardiotocograms, meconium liquor, a low Apgar score at birth, gestation less than 37 weeks, and birth weight less than 2500 g. It was not possible to use a low risk population as comparator because only one included study met the criteria for this definition.41 Given the reporting quality of the primary studies it was also not possible to explore other potential sources of heterogeneity. Metaregression analysis was univariate throughout, in accordance with published guidance that recommends allowing at least 10 studies per covariate explored.42 When a reason for heterogeneity was identified, we carried out subgroup analyses. As complications such as cerebral palsy and intraventricular haemorrhage have been shown to be increased in preterm and low birthweight infants we analysed studies with these populations separately and compared the results with that of a term population.

As clinical heterogeneity was present between studies, we used a random effects model throughout. The presence of publication bias was determined using the Harbord test.42 43 To assess the effect of the use of different thresholds to define low pH, we repeated the meta-analyses using the bivariate method, which takes into account any threshold effect.44 We additionally analysed subgroups within the outcome measures of neonatal mortality and neonatal morbidity according to the arterial pH threshold reported (<7.00, <7.10, and <7.20). We statistically analysed data using Meta-Disc 1.3 software,45 and Stata version 10.0 using the metan, metandi, and meta-bias commands.46 47 48

To assess a causal association for each outcome we considered Hill’s criteria.21 25 We examined strength of association using point estimates of odds ratios and consistency using the direction of association in the forest plots and heterogeneity statistics.


An initial search of 5690 citations identified 51 primary articles1 4 5 10 11 41 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91, two after obtaining information from the authors (fig 11).92 93 The included studies totalled 481 753 infants. Overall, 190 2×2 tables were produced; 43 of the studies providing these data were eligible for inclusion in meta-analyses according to predefined outcome measures, totalling 479 383 infants and 70 2×2 tables. One included study was thought to contain duplication60; however, the outcomes reported were different and therefore both papers60 61 were included in the review in separate meta-analyses. When more than one 2×2 table was produced per study, double counting of infants in any one analysis was avoided.

figure malg700435.f1_default
Fig 1 Study selection process

The included studies used various index tests (table 11):): most papers (n=46) reported arterial cord pH, with thresholds ranging from 7.00 to 7.24. Arterial base excess was reported in four studies, with thresholds of 12-16 mmol/l.61 73 81 91 Five studies reported venous cord pH; three using a threshold of 7.20 and one a threshold of 7.10.55 69 78 85 93 Only one study utilised venous base excess.93 The cord pH level was obtained before the occurrence of the adverse outcome. A wide variety of outcome measures were reported, ranging from neonatal mortality and morbidity to long term outcomes, including cerebral palsy, unspecified neurological abnormality, IQs, and developmental assessments (for example, Bayley and Griffiths scores). When the same outcome was reported, the thresholds and ages at assessment varied between studies, therefore meta-analysis was not possible for long term outcomes other than cerebral palsy. The odds ratio point estimate varied widely. Thirty six studies reported on outcomes within the neonatal period only. Fifteen studies had long term follow-up; one did not report the age of ascertainment of the outcome. The age range reported in other studies was 1 to 8 years; the median across studies was 5 years.

Table 1
 Studies included in systematic review of association between cord pH at birth and neonatal and long term outcomes

Quality assessment

Overall, study quality was variable (table 22).). Most studies were retrospective but with a cohort design, allowing inferences on temporality of association. Over 80% of studies met the following quality items: appropriate outcome measure, more than 90% verification with outcome measure, and cohort design. Studies scored poorly for adequate description of index test and outcome measure, and consecutive recruitment. All included studies were unclear about the use of medical intervention between the index test and outcome measure. Overall, 45% (n=23) of studies were of high quality, 39% (n=20) of medium quality, and 16% (n=8) of low quality. Study design and quality did not seem to influence results on metaregression (table 33).

Table 2
 Methodological quality of studies in systematic review of association between low cord pH at birth and neonatal and long term morbidity
Table 3
 Exploration of heterogeneity in estimation of association between low arterial cord pH at birth and neonatal mortality and morbidity

Association between cord pH and neonatal mortality

Fifteen studies (13 cohort, two case-control) totalling 469 395 infants reported on the association between arterial cord pH and mortality. The Harbord test was not significant, suggesting no influence of small study effect (see web extra on All studies had an odds ratio point estimate greater than 1.0. Heterogeneity was significant (I2=61.0%) overall. Metaregression (table 3) identified population risk as a significant explanatory factor. Within subgroups (fig 22)) the association was consistent across studies. The association of low arterial cord pH with neonatal mortality was stronger in the unselected population (odds ratio 16.9, 95% confidence interval 9.7 to 29.5, estimated predictive interval 5.0-57.3, I2=0.0%) than in the high risk population (4.2, 2.6 to 6.9, 1.3-13.7, I2=35.1%). The analysis for the unselected population was dominated by one large study,1 which was based on data from a regional perinatal register where cord pH was determined at most of the births. A sensitivity analysis excluding this study this did not significantly alter the point estimate (17.0, 4.4 to 65.5); however, the estimated predictive interval became wide (0.0-106 299.0)

figure malg700435.f2_default
Fig 2 Association of low arterial cord pH with neonatal mortality. EPI=estimated predictive interval

Examination of the high risk population further showed that when studies reporting on a population of infants born at less than 32 weeks’ gestation, or with a birth weight of less than 2000 g, were analysed separately (seven studies), a significant association was found between cord pH and mortality (3.5, 2.3 to 5.4, I2=0.0%). When limited to a term (>37 weeks’ gestation) population (four studies), the association was also strong (9.3, 1.4 to 63.2, I2=84.0%); however, heterogeneity was significant and the predictive interval broad (0.0-38 169.8). Grouping the studies according to quality did not affect the significance or direction of association of the pooled result (fig 2). Exploration for a threshold effect (table 44)) showed that for a cut-off pH threshold of 7.00 the association did not reach significance overall (6.1, 0.9 to 41.6) and the predictive interval was broad (0.0-20 406.6). The results for a threshold of 7.10 gave a similar point estimate but achieved significance (7.1, 3.3 to 15.3); however, the predictive interval remained broad (0.8-64.3) and crossed the line of no effect. For a threshold of 7.20, the odds ratio was lower (4.3, 2.2 to 8.7), with a broad predictive interval (0.5-40.6). Only one study examined all three thresholds,1 with the strongest association at threshold 7.00 (16.9, 9.2 to 31.1) and the weakest at 7.20 (3.1, 2.3 to 4.1).

Table 4
 Effect of using varying thresholds of arterial cord pH at birth on accuracy to predict neonatal morbidity and mortality

Association between cord pH and neonatal morbidity

Thirty one studies compared arterial cord pH with a variety of neonatal outcomes (fig 33).). One of these61 was excluded from meta-analysis of composite neonatal morbidity because it contained a duplicate population to another included study,60 therefore the dataset to assess the association of arterial pH with a composite measure of morbidity included 30 studies with 10 904 infants. The Harbord test was significant, suggesting the presence of a small study effect (see web extra on Only two studies had an odds ratio point estimate of less than 1.0, the rest showing an association. Significant heterogeneity was, however, present (I2=58.2%). Metaregression showed population to be an explanatory variable (table 3). Subgroup meta-analysis for a high risk population (fig 3) showed a weaker association (3.4, 2.3 to 4.9, 1.4-8.4, I2=26.4%) than in an unselected or undefined population (10.6, 4.7 to 24.1, 0.8-135.8, I2=66.4%). When analysed in subgroups according to quality, the direction of effect remained consistent and significant between the group of 12 high quality studies (6.6, 3.7 to 11.8, 1.3-32.6, I2=51.2%) and 18 low or medium quality studies (4.6, 2.6 to 8.0, 0.7-29.2, I2=61.5%). Exploration by subgroup analysis for a threshold effect (table 4) showed the most substantial association at a pH threshold of 7.00 (12.5, 6.1 to 25.6). The predictive interval was broad but did not cross the line of no effect (1.7-89.9). The results were similar for a threshold of 7.10 (2.4, 1.3 to 4.3) and 7.20 (2.2, 1.3 to 3.7).

figure malg700435.f3_default
Fig 3 Association of low arterial cord pH with neonatal morbidity. HIE=hypoxic ischaemic encephalopathy; IVH=intraventricular haemorrhage; PVL=periventricular leucomalacia; NS=not stated; WM=cerebral white matter; EPI=estimated predictive interval ...

When components of the composite outcome were analysed (fig 3), the odds ratio for an association between arterial cord pH and hypoxic ischaemic encephalopathy was 13.8 (6.6 to 28.9, 5.2-36.4, I2=0.0%), between arterial cord pH and seizures was 8.1 (3.0 to 21.9, 0.4-153.6, I2=66.3%), and between intraventricular haemorrhage or periventricular leucomalacia was 2.9 (2.1 to 4.1, 2.0-4.3, I2=0.0%). Only two of nine studies reporting this outcome were not limited to a preterm (<32 weeks) or low birthweight (<2000 g) population. Excluding these two studies did not affect the strength or significance of the association.

Five studies reported on the association between venous cord pH and neonatal morbidity.55 69 78 85 93 Meta-analysis showed a significant association (4.0, 1.2 to 13.3, I2=44.5%). However the predictive interval crossed the line of no effect (0.1-125.3). Four studies examined the association between arterial base excess and neonatal morbidity, which was similar to venous cord pH and also had an estimated predictive interval that crossed the line of no effect (2.5, 1.3 to 4.8, 0.6-10.4, I2=0.0%).61 73 81 91 Owing to the small number of studies reporting this variable, it was not possible to combine the cord pH and base excess to compare the difference between respiratory and metabolic acidosis.

Association between cord pH and cerebral palsy

Seven studies totalling 1117 infants examined the association between arterial cord pH and cerebral palsy.4 5 49 68 74 75 81 Of those, two had an odds ratio point estimate of less than 1.0, but the rest showed an association of low pH with cerebral palsy (table 4). Only two studies gave the criteria used to diagnose cerebral palsy.49 75 The overall association was odds ratio 2.3 (1.3 to 4.2, 1.1-5.0, I2=0.0%l fig 44).). It was not possible to explore the threshold effect by subgroup analysis owing to the small number of studies reporting this outcome, therefore bivariate meta-analysis was carried out, which did not change the overall results (2.1, 1.2 to 4.1).

figure malg700435.f4_default
Fig 4 Association of low arterial cord pH with cerebral palsy. NS=not stated; EPI=estimated predictive interval


Low arterial umbilical cord pH had a strong, consistent, and temporal association with neonatal mortality and morbidity (composite of hypoxic ischaemic encephalopathy, seizures, and intraventricular haemorrhage or periventricular leucomalacia) and long term outcome (cerebral palsy). In all of the associations between arterial cord pH and outcome explored, with the exception of composite morbidity in a low risk population and seizures, the estimated predictive interval suggested that a future study would have the same direction and significance of effect observed. The associations observed are biologically plausible.6 94 95 96

Strengths and limitations of the review

This review provides the best available evidence, at the time of publication, of the association between cord pH at birth and outcomes. The strength of our review and the validity of our inferences lie in the methods used. We complied with existing guidelines for the reporting of systematic reviews of diagnostic22 97 and observational studies evaluating causal association.15 25 We used the most up to date techniques for carrying out and interpreting meta-analysis.35 44 An extensive literature search was done in relevant databases with no language restrictions applied. The studies we pooled had heterogeneity in terms of quality, population risk, threshold of cord pH used, and ascertainment of neonatal outcome. We carried out recommended analyses to tackle this problem, including bivariate and subgroup meta-analysis to take into account the threshold effect,44 metaregression analysis to explore reasons for heterogeneity,39 and component outcome analysis to examine the suitability of the composite morbidity outcome. This did not significantly affect our results. Recent work suggesting the differences between standard and bivariate techniques may be small.98 The observed associations were qualitatively in the same direction, and statistical heterogeneity, when present, arose from variation in strength of associations from study to study rather than opposition in direction of association. We are therefore confident that our inference concerning a causal association between low arterial cord pH at birth and neonatal mortality and a variety of neonatal morbidities merits consideration.

This review has several limitations. Despite our efforts to search for published and unpublished literature, the Harbord test suggested that the meta-analysis of the relation of arterial cord pH and neonatal morbidity may be affected by small study bias. The quality of the primary studies varied. We used both metaregression and subgroup analysis to explore for the effect of this problem, which showed that study quality did not affect our inferences. The poor reporting of population characteristics limited the subgroup analysis according to risk factors: a large number of the papers with an “unselected” population did not fully report characteristics such as birth weight or gestational age, making it difficult to extrapolate our findings to the general obstetric population. Only one paper included in the meta-analysis specified that it was limited to a low risk term population. With regard to the index test examined, only a small number of papers reported base excess, which meant that it was not possible to compare metabolic acidosis with respiratory acidosis. We found that a high base excess was associated with neonatal morbidity, but in clinical practice the pH and base excess level would be considered together in any infant, and we are unable to comment on this. Additionally, we were only able to base our analysis on the thresholds reported in the primary studies, which limited our exploration of the effect of varying pH levels. Some of these issues may be dealt with using meta-analysis of individual patient data.99

Venous cord pH and arterial base excess showed weaker associations with neonatal morbidity than that of arterial cord pH, with estimated predictive intervals that crossed the line of no effect. This analysis was, however, based on a small number of studies, and as no other subgroup analysis could be done, a direct comparison with arterial cord pH was not possible. It seems likely from our results that arterial cord pH has a stronger association with outcome than venous cord pH.

Evidence supporting causality of association of low arterial cord pH with adverse outcomes

Hypoxic ischaemia initiates energy depletion, the accumulation of extracellular glutamate, and activation of receptors, leading to a deleterious cascade of events resulting in neuronal death.100 However, different areas of the brain are susceptible to injury at various stages in development, and the consequences of injury are unpredictable.101 This would support our findings of a strong association with hypoxic ischaemic encephalopathy but a weaker association with cerebral palsy. Only 10% of infants with evidence of hypoxic ischaemic encephalopathy develop cerebral palsy, but the reasons for this are not yet fully understood.102 This issue is further highlighted by the findings of the term breech trial, where long term follow-up did not show any difference in neurodevelopmental delay, despite an apparent increase in neonatal morbidity in the vaginal breech group.103

It is difficult to comment on the specificity with which cord pH is associated with the outcomes examined within our review. All of the outcomes may arise from a variety of causes—for example, in addition to hypoxia, neonatal seizures may be caused by congenital brain anomaly, infection, and metabolic disorders. Although some of the included studies excluded infants with congenital anomaly, others did not specify whether they had excluded from their analysis infants with an outcome related to another cause. This may explain why the strength of association of arterial cord pH with neonatal mortality and morbidity was stronger in the unselected group than in the high risk group. The infants in the high risk group had other factors (for example, prematurity, low birth weight) that may have contributed to the adverse outcome, thus diluting the strength of association. This is supported by the higher number of deaths in the high risk population, with a higher specificity for low arterial cord pH and death in the unselected population.

We explored for the presence of a dose-response relation by examining the strength of association between arterial cord pH and neonatal mortality and morbidity at different pH thresholds. Although the meta-analysis did not show a clear dose-response relation, and the estimated predictive intervals were broad, the association for both neonatal mortality and neonatal morbidity was weakest at the highest threshold. Only one study1 explored the association of arterial cord pH and neonatal mortality at all three thresholds examined. A clear dose-response relation was apparent within this study, with the strongest association at a threshold of 7.00 and the weakest at a threshold of 7.20. Comparison within a study may be more valid than comparisons between studies as it avoids confounding by other study level factors.

Conclusions and practice implications

Our review did not explore the use of cord pH as a prognostic test, and therefore the extent to which our results can be used to counsel parents and target interventions for infants with a low cord pH at birth is limited. To explore this matter, further research is required. A recent review highlighted the current deficits in prognosis research and suggested that when high quality primary studies exist, meta-analysis of individual patient data enables the prognostic value of a test to be assessed at an individual level.104 Our review, however, highlights the lack of high quality primary studies, and therefore a large prospective cohort study with long term follow-up and accounting for potential confounding factors is required. Such a study must include evaluation of outcomes relevant to the individual and society, such as impaired development and use of healthcare and educational resources, before the evaluation of use of cord pH as a prognostic test and its cost effectiveness. This will enable further exploration of the threshold effect and the use of combined cord pH and base excess to predict outcome.

Cord pH is currently assessed in infants believed to be at high risk for neonatal asphyxia. Our results suggest, however, that the strength of association with cord pH and outcome is not limited to this high risk population. Therefore future research should assess the use of cord pH across neonatal populations, particularly exploring the cost effectiveness of testing all neonates. Systematic reviews to establish the association of other neonatal wellbeing measures with long term outcomes are ongoing in our department.

Based on our review, increased initial surveillance of neonates born with a low arterial cord pH, regardless of their clinical condition, is warranted as the odds of complications have been shown to be higher in this group. The avoidance of a low cord pH at birth should continue to be a target for day to day obstetric practice. Our findings justify the use of arterial cord pH as an important outcome measure alongside neonatal morbidity and mortality in obstetric clinical trials. It is difficult to draw strong conclusions on the necessity of long term follow-up for babies with low arterial cord pH, as the observed association with cerebral palsy was in a limited number of primary studies and the association, although statistically significant, was only moderately strong and based on studies of varying quality. We therefore support the use of long term follow-up with childhood assessments in obstetric trials, as this may show developmental anomalies and allow evaluation of cord pH as a predictive test for these outcomes.

What is already known on this topic

  • Umbilical cord pH at birth is frequently used to measure perinatal asphyxia
  • Neonatal and childhood mortality and morbidity, including cerebral palsy, are often attributed to fetal acidosis, as defined by a low cord pH at birth
  • Existing reports of the association between cord pH and adverse outcome are conflicting

What this study adds

  • Low cord pH is substantially associated with neonatal mortality and morbidity and cerebral palsy in childhood
  • These outcomes justify the increased surveillance of infants born with a low cord pH
  • Further research is, however, needed to explore the cost effectiveness of doing this test in all neonates

Web Extra. Extra material supplied by the author

Web ExtraExtra material supplied by the author

Medline search strategy

Results of Harbord test


Zainab Laftah helped with data extraction. Richard Riley provided statistical expertise and advice.

Contributors: GLM designed the review; extracted, analysed, and interpreted the data, drafted the article; and is responsible for the integrity of the work. She is the guarantor. RKM extracted and interpreted the data, revised the article critically for intellectual content, and approved the final draft for publication. KSK conceived the review, helped analyse and interpret the data, revised the article critically for intellectual content, and approved the final draft for publication.

Funding: GLM is funded by the Mary Crosse fellowship, Birmingham Women’s Foundation Trust. RKM is funded by a Medical Research Council/Royal College of Obstetrics and Gynaecology clinical research training fellowship (RRAK12923).

Competing interests: All authors have completed the unified competing interest form at (available on request from the corresponding author) and declare (1) no financial support for the submitted work from anyone other than their employer; (2) no financial relationships with commercial entities that might have an interest in the submitted work; (3) no spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; and (4) no non-financial interests that may be relevant to the submitted work.

Ethical approval: Not required.

Data sharing: The odds ratios for outcomes included in table 1 but not reported in the paper are available from the author on request.


Cite this as: BMJ 2010;340:c1471


1. Heller G, Schnell RR, Misselwitz B, Schmidt S. Umbilical blood pH, Apgar scores, and early neonatal mortality. Z Geburtshilfe Neonatol 2003;207:84-9. [PubMed]
2. Goodwin TM, Belai I, Hernandez P, Durand M, Paul RH. Asphyxial complications in the term newborn with severe umbilical acidemia. Am J Obstet Gynecol 1992;167:1506-12. [PubMed]
3. Williams KP, Singh A. The correlation of seizures in newborn infants with significant acidosis at birth with umbilical artery cord gas values. Obstet Gynecol 2002;100:557-60. [PubMed]
4. Beeby PJ, Elliott EJ, Henderson-Smart DJ, Rieger ID. Predictive value of umbilical artery pH in preterm infants. Arch Dis Child 1994;71:F93-6. [PMC free article] [PubMed]
5. Kato EH, Yamada H, Matsumoto Y, Hattori S, Makinoda S, Fujimoto S. Relation between perinatal factors and outcome of very low birth weight infants. J Perinat Med 1996;24:677-86. [PubMed]
6. Fahey J, King TL. Intrauterine asphyxia: clinical implications for providers of intrapartum care. J Midwifery Women’s Health 2005;50:498-506. [PubMed]
7. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999;319:1054-9. [PMC free article] [PubMed]
8. Dear P, Newell S, Rosenbloom L, Rennie JM, MacLennan A. Establishing probable cause in cerebral palsy [letter]. BMJ 2000;320:1075.
9. Dijxhoorn MJ, Visser GH, Huisjes HJ, Fidler V, Touwen BC. The relation between umbilical pH values and neonatal neurological morbidity in full term appropriate-for-dates infants. Early Hum Dev 1985;11:33-42. [PubMed]
10. Van den Berg PP, Nelen WL, Jongsma HW, Nijland R, Kollée LA, Nijhuis JG, et al. Neonatal complications in newborns with an umbilical artery pH<7.00. Am J Obstet Gynecol 1996;175:1152-7. [PubMed]
11. Wildschut J, Feron FJ, Hendriksen JG, van Hall M, Gavilanes-Jiminez DW, Hadders-Algra M, et al. Acid-base status at birth, spontaneous motor behaviour at term and 3 months and neurodevelopmental outcome at age 4 years in full-term infants. Early Hum Dev 2005;81:535-44. [PubMed]
12. Goldaber KG, Gilstrap LC 3rd, Leveno KJ, Dax JS, McIntire DD. Pathologic fetal acidemia. Obstet Gynecol 1991;78:1103-7. [PubMed]
13. Ross MG, Gala R. Use of umbilical artery base excess: algorithm for the timing of hypoxic injury. Am J Obstet Gynecol 2002;187:1-9. [PubMed]
14. Van de Riet JE, Vandenbussche FP, Le Cessie S, Keirse MJ. Newborn assessment and long-term adverse outcome: a systematic review. Am J Obstet Gynecol 1999;180:1024-9. [PubMed]
15. Stroup DF, Berlin JA, Morton SC, Olkin I. Meta-analysis of observational studies in epidemiology. JAMA 2000;283:2008-12. [PubMed]
16. Shennan AH, Smith R, Browne D, Edmonds DK, Morgan B. The elective use of oxytocin infusion during labour in nulliparous women using epidural analgesia: a randomised double-blind placebo-controlled trial. Int J Obstet Anesth 1995;4:78-81. [PubMed]
17. Cluett ER, Pickering RM, Getliffe K, St George Saunders NJ. Randomised controlled trial of labouring in water compared with standard of augmentation for management of dystocia in first stage of labour. BMJ 2004;328:314-8. [PMC free article] [PubMed]
18. Hansen SL, Clark SL, Foster JC. Active pushing versus passive fetal descent in the second stage of labor: a randomized controlled trial. Obstet Gynecol 2002;99:29-34. [PubMed]
19. Cottee C, Harding K. Risk management in obstetrics. Obstet, Gynaecol Reprod Med 2008;18:155-62.
21. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300. [PMC free article] [PubMed]
22. Khan KS, Dinnes J, Kleijnen J. Systematic reviews to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol 2001;95:6-11. [PubMed]
23. Akers J, Aguiar-Ibanez R, Sari ABA, Benyon S, Booth A, Burch J, et al. Systematic reviews. CRD’s guidance for undertaking reviews in health care. Centre for Reviews and Dissemination, University of York, 2009.
24. Deville W, Buntinx F. Guidelines for conducting systematic reviews of studies evaluating the accuracy of diagnostic studies. In: Knotterus JA, ed. The evidence base of clinical diagnosis. BMJ Publishing Group, 2002:145-65.
25. Weed DL. Interpreting epidemiological evidence: how meta-analysis and causal inference methods are related. Int J Epidemiol 2000;29:387-90. [PubMed]
26. Weed DL. On the use of causal criteria. Int J Epidemiol 1997;26:1137-41. [PubMed]
27. Weed DL, Hursting SD. Biological plausibility in causal inference: current method and practice. Am J Epidemiol 1998;147:415-25. [PubMed]
28. Fox C, Mignini L, Khan KS. Systematic reviews of research to assess causation: a guide to methods and application. Eur Clinics Obstet Gynecol 2006;1:251-6.
29. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-4. [PMC free article] [PubMed]
30. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25. [PMC free article] [PubMed]
31. Whiting P, Harbord R, Kleijnen J. No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Med Res Methodol 2005;5:19. [PMC free article] [PubMed]
32. Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6. [PMC free article] [PubMed]
33. Deeks J. Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001;323:157-62. [PMC free article] [PubMed]
34. Greenland S. Interpretation and choice of effect measures in epidemiologic analyses. Am J Epidemiol 1987;125:761-8. [PubMed]
35. Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Statist Soc A 2009;172:137-59. [PMC free article] [PubMed]
36. Sankey S, Weissfeld L, Fine M, Kapoor W. An assessment of the use of the continuity correction for sparse data in meta-analysis. Commun Stat Simul Comput 1996;25:1031-56.
37. Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized controlled trials: greater precision but with greater uncertainty? JAMA 2003;289:2554-9. [PubMed]
38. Higgins JP, Thompson SG, Deeks JJ. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. [PMC free article] [PubMed]
39. Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002;21:1525-37. [PubMed]
40. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001;323:101-5. [PMC free article] [PubMed]
41. Dijxhoorn MJ, Visser GH, Fidler V, Touwen BC, Huisjes HJ. Apgar score, meconium and acidaemia at birth in relation to neonatal neurological morbidity in term infants. BJOG 1986;93:217-22. [PubMed]
42. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Cochrane Collaboration, 2009.
43. Harbord RM, Egger M, Sterne JA. A modified test for small study effects in meta-analysis of controlled trials with binary end points. Stat Med 2006;25:3443-57. [PubMed]
44. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate meta-analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005;58:982-90. [PubMed]
45. Zamora J, Abraira V, Muriel A, Khan KS, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2003;12:31. [PMC free article] [PubMed]
46. Harbord RM, Harris RJ, Sterne JAC, Steichen T. METABIAS: Stata module to test for small-study effects in meta-analysis. Statistical Software Components S404901, Boston College Department of Economics, 2009.
47. Harris R, Bradburn M, Deeks J, Harbord R, Altman D, Steichen T, et al. METAN: Stata module for fixed and random effects meta-analysis. Statistical Software Components S456798, Boston College Department of Economics, 2009.
48. Harbord R. METANDI: Stata module to perform meta-analysis of diagnostic accuracy. Statistical Software Components S456932, Boston College Department of Economics, 2008.
49. Gaudier FL, Goldenberg RL, Nelson KG, Peralta-Carcelen M, Johnson SE, DuBard MB, et al.Acid-base status at birth and subsequent neurosensory impairment in surviving 500 to 1000 gm infants. Am J Obstet Gynecol 1994;170:48-53. [PubMed]
50. Baenziger O, Moenkhoff M, Morales CG, Waldvogel K, Wolf M, Bucher H, et al. Impaired chemical coupling of cerebral blood flow is compatible with intact neurological outcome in neonates with perinatal risk factors. Biol Neonate 1999;75:9-17. [PubMed]
51. Bresadola M, Lo Mastro M, Arena V, Bellaveglia L, Scarpellini F. Preterm labour and neonatal parameters. Clin Exp Obstet Gynecol 1995;3:235-9. [PubMed]
52. Blackwell SC, Moldenhauer J, Hassan SS, Redman ME, Refuerzo JS, Berry SM, et al. Meconium aspiration syndrome in term neonates with normal acid-base status at delivery: is it different? Am J Obstet Gynecol 2001;184:1422-5. [PubMed]
53. Casey BM, Goldaber KG, McIntire DD. Outcomes amongst term infants when two-hour postnatal pH is compared with pH at delivery. Am J Obstet Gynecol 2001;184:447-50. [PubMed]
54. Dennis J, Johnson A, Mutch L, Yudkin P, Johnson P. Acid-base status at birth and neurodevelopmental outcome at four and one-half years. Am J Obstet Gynecol 1989;161:213-20. [PubMed]
55. D’Souza SW, Black P, Cadman J, Richards B. Umbilical venous blood pH: a useful aid in the diagnosis of asphyxia at birth. Arch Dis Child 1983;58:15-9. [PMC free article] [PubMed]
56. Engle D, Laptook AR, Perlman J. Acute changes in arterial carbon dioxide tension and acid-base status and early neurologic characteristics in term infants following perinatal asphyxia. Resuscitation 1999;42:11-7. [PubMed]
57. Ghosh BM. Prediction of perinatal asphyxia with nucleated red blood cells in cord blood of newborns. Int J Gynecol Obstet 2003;81:267-71. [PubMed]
58. Gilstrap LC 3rd, Leveno KJ, Burris J, Williams ML, Little BB. Diagnosis of birth asphyxia on the basis of fetal pH, Apgar score, and newborn cerebral dysfunction. Am J Obstet Gynecol 1989;161:825-30. [PubMed]
59. Gonzalez de Dios J, Moya M, Carratala F. Neurological evolution of asphytic full-term newborns with severe umbilical acidosis (pHUA <7.00). Rev Neurol 2000;31:107-13. [PubMed]
60. Graham EM, Holcroft CJ, Blakemore KJ. Evidence of intrapartum hypoxia-ischemia is not present in the majority of cases of neonatal seizures. J Matern Fetal Neonatal Med 2002;12:123-6. [PubMed]
61. Graham EM, Holcroft CJ, Karishma KR, Donohue PK, Allen MC. Neonatal cerebral white matter injury in preterm infants is associated with culture positive infections and only rarely with metabolic acidosis. Am J Obstet Gynecol 2004;191:1305-10. [PubMed]
62. Haddad B, Mercer BM, Livingston JC, Talati A, Sibai BM. Outcome after successful resuscitation of babies born with Apgar scores of 0 at both 1 and 5 minutes. Am J Obstet Gynecol 2000;182:1210-4. [PubMed]
63. Hernandez C, Little BB, Dax JS, Gilstrap LC 3rd, Rosenfeld CR. Prediction of the severity of meconium aspiration syndrome. Am J Obstet Gynecol 1993;169:61-70. [PubMed]
64. Hibbard JU, Hibbard MC, Whalen MP. Umbilical cord blood gases and mortality and morbidity in the very low birth weight infant. Obstet Gynecol 1991;78:768-73. [PubMed]
65. Hogan LI, Ingemarrson I, Thorngren-Jerneck K, Herbst A. How often is a low 5-min Apgar score in term newborns due to asphyxia? Eur J Obstet Gynecol Reprod Biol 2007;130:169-75. [PubMed]
66. Holmes P, Oppenheimer LW, Gravelle A, Walker M, Blayney M. The effect of variable heart rate decelerations on intraventricular hemorrhage and other perinatal outcomes in preterm infants. J Matern Fetal Med 2001;10:264-8. [PubMed]
67. Huisjes HJ, Aarnoudse JG. Arterial or venous umbilical pH as a measure of neonatal morbidity? Early Hum Dev 1979;3:155-61. [PubMed]
68. Ingemarsson I, Herbst A, Thorngren-Jerneck K. Long term outcome after umbilical artery acidaemia at term birth: influence of gender and duration of fetal heart rate abnormalities. BJOG 1997;104:1123-7. [PubMed]
69. Jurgens-van der Zee AD, Bierman-van Eendenburg MEC, Fidler V, Olinga AA, Visch JH, Touwen BC, et al. Preterm birth, growth retardation and acidemia in relation to neurological abnormality of the newborn. Early Hum Dev 1979;32:141-54. [PubMed]
70. Larma JD, Silva AM, Holcroft CJ, Thompson RE, Donohue PK, Graham EM. Intrapartum electronic fetal heart rate monitoring and the identification of metabolic acidosis and hypoxic-ischemic encephalopathy. Am J Obstet Gynecol 2007;197:301-8. [PubMed]
71. Litschgi M, Benz JJ, Glatthaar E. Actual and prognostic value of arterial cord pH for the newborn infant. Z Geburtshilfe Perinatol 1974;178:23-9. [PubMed]
72. Loh SF, Woodworth A, Yeo GS. Umbilical cord blood gas analysis at delivery. Singapore Med J 1998;39:151-5. [PubMed]
73. Low JA. Threshold of metabolic acidosis associated with newborn complications. Am J Obstet Gynecol 1997;177:1391-4. [PubMed]
74. Luthy DA, Shy KK, Strickland D, Wilson J, Bennett FC, Brown ZA, et al. Status of infants at birth and risk for adverse neonatal events and long-term sequelae: a study in low birth weight infants. Am J Obstet Gynecol 1987;157:676-9. [PubMed]
75. Murphy DJ, Sellers S, MacKenzie IZ, Yudkin P, Johnson A. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet 1995;346:1449-54. [PubMed]
76. Perlman JM, Risser R. Can asphyxiated infants at risk for neonatal seizures be rapidly identified by current high-risk markers? Pediatrics 1996;97:456-62. [PubMed]
77. Sakuraba M, Saling E. Umbilical cord blood coagulability, acidosis and intracranial hemorrhage. J Perinat Med 1989;17:99-106. [PubMed]
78. Salafia CM, Minior VK, Rosenkrantz TS, Pezzullo JC, Popek EJ, Cusick W, et al. Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks’ gestation. Am J Perinatol 1995;12:429-36. [PubMed]
79. Schneider R, Tanner R. Perinatal umbilical artery pH and cerebral function disorders in twins starting school. Z Kinder Jugendpsychiatr 1985;13:24-30. [PubMed]
80. Silva AM, Cootauco AC, Aina-Mumuney A, Donohue PK, Graham EM. The association of hypotonia and depression in the term and near-term neonate with metabolic acidemia. J Perinat Med 2008;36:151-6. [PubMed]
81. Socol ML. Depressed Apgar score, acid-base balance and neurologic outcome. Am J Obstet Gynecol 1994;170:991-9. [PubMed]
82. Spinillo A, Fazzi E, Orcesi S. Perinatal factors and 2 year minor neurodevelopmental impairment in low birth weight infants. Biol Neonate 1995;67:39-46. [PubMed]
83. Tejani N, Verma U. Correlation of Apgar scores and umbilical artery acid-base status to mortality and morbidity in the low birth weight neonate. Obstet Gynecol 1989;73:597-600. [PubMed]
84. Thoulon JM, Varnier C, Faure M. Prognostic value of umbilical blood pH measurement in newborn infants at birth. Lyon Med 1972;227:699-702. [PubMed]
85. Valentin L, Ekman G, Isberg PE, Polberger S, Marsál K. Clinical evaluation of the fetus and neonate. Relation between intra-partum cardiotocography, Apgar score, cord blood acid-base status and neonatal morbidity. Arch Gynecol Obstet 1993;253:103-15. [PubMed]
86. Winkler CL, Hauth JC, Tucker JM, Owen J, Brumfield CG. Neonatal complications at term as related to the degree of umbilical artery acidaemia. Am J Obstet Gynecol 1991;164:637-41. [PubMed]
87. Wu L, Thorngren-Jerneck K, Ingemarsson I. Different types of acidemia at birth, fetal heart rate patterns and infants outcome at four years of age. Chung-Hua Fu Chan Ko Tsa Chih 1998;33:462-5. [PubMed]
88. Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433-40. [PubMed]
89. Yudkin P, Johnson A, Clover LM, Murphy KW. Clustering of perinatal markers of birth asphyxia and outcome age 5 years. BJOG 1994;101:774-81. [PubMed]
90. Vintzileos AM, Antsaklis A, Varvarigos I, Papas C, Sofatzis I, Montgomery JT. A randomized trial of intrapartum electronic fetal heart rate monitoring versus intermittent auscultation. Obstet Gynecol 1993;81:899-907. [PubMed]
91. Ertan AK, Tanriverdi HA, Meier M, Schmidt W. Perinatal risk factors for neonatal intracerebral hemorrhage in preterm infants. Eur J Obstet Gynecol Reprod Biol 2006;127:29-34. [PubMed]
92. Svirko E, Mellanby J, Impey L. The association between cord pH at birth and intellectual function in childhood. Early Hum Dev 2008;84:37-41. [PubMed]
93. Gea YA. Clinical value of lactate measurement and nucleated red blood cell counts in the placental segment of the umbilical vein of premature newborns for diagnosis of hypoxia-ischemia. J Pediatr (Rio J) 2007;83:186-90. [PubMed]
94. Thorp JA, Rushing R. Umbilical cord blood gas analysis. Obstet Gynecol Clin North Am 1999;26:695-709. [PubMed]
95. Ferriero DM. Neonatal brain injury. N Engl J Med 2004;351:1985-95. [PubMed]
96. Johnston MV, Trescher WH, Ishida A, Nakajima W. Neurobiology of hypoxic ischemic injury in the developing brain. J Child Neurol 2001;15:588-91.
97. Jaeschke R, Guyatt GH, Sackett DL. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B What are the results and will they help me in caring for my patients? JAMA 1994;271:703-7. [PubMed]
98. Simel D, Bossuyt PM. Differences between univariate and bivariate models for summarizing diagnostic accuracy may not be large. J Clin Epidemiol 2009;62:1292-300. [PubMed]
99. Khan KS, Bachmann LM, ter Riet G. Systematic reviews with individual patient data meta-analysis to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol 2003;108:121-5. [PubMed]
100. Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev 2001;7:56-64. [PubMed]
101. Hossain MA. Hypoxic ischemic injury in neonatal brain: involvement of a novel neuronal molecule in neuronal cell death and potential target for neuroprotection. Int J Dev Neurosci 2008;26:93-101. [PMC free article] [PubMed]
102. Blumenthal I. Cerebral palsy—medicolegal aspects. J R Soc Med 2001;94:624-6. [PMC free article] [PubMed]
103. Whyte H, Hannah ME, Saigal S, Hannah WJ, Hewson S, Amankwah K, et al. Outcomes of children at 2 years after planned cesarean birth versus planned vaginal birth for breech presentation at term: the international randomized term breech trial. Am J Obstet Gynecol 2004;191:864-71. [PubMed]
104. Hemingway H, Riley RD, Altman D. Ten steps towards improving prognosis research. BMJ 2009;339:b4184. [PubMed]

Articles from The BMJ are provided here courtesy of BMJ Publishing Group